IVCare study for safer central line care
Part of Infections clinical trials.
This study tests different ways to secure and care for central lines (special tubes that deliver medicine or fluids) to reduce infections and improve comfort. It may help find the best method for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or need a central line (a long, thin tube placed in a large vein, like a PICC or CVC).
- You are under 18 years old and the study site has not yet approved enrolling children.
- You do not have a current or recent bloodstream infection from a line, and you are not receiving treatment for one.
- You are not expected to live less than 30 days or are not on comfort-only care.
- You have not been in this study before for the same line, and you have not been in it three times total.
- For the securement part: your skin at the insertion site is healthy, and the SecurAcath device can be used safely.
- For the connectors part: you are not allergic to chlorhexidine (a common antiseptic).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether putting a small cap containing chlorhexidine (a germ-killing medicine) on the end of the dialysis catheter can prevent serious bloodstream infections. If you are on dialysis with a catheter, this may help reduce your risk of infection.
This study looks at ways to reduce problems that can happen with a type of long-term IV line called a PICC line. It is for people who are independent and able to care for themselves, and it aims to make managing the line safer and easier.
This trial tests a new medical device that gives medication to patients in the intensive care unit (ICU). It aims to see if the device works safely and effectively.
This study looks at ways to reduce problems (like infections or blockages) that can happen with a PICC line, a thin tube placed in a vein to give medicine or fluids. If you are independent and will have your PICC for at least two weeks, this research may help you get safer care.
This trial is testing whether a special medical adhesive and protective barrier can reduce skin damage (MARSI) from the dressing used to hold a central line in place. It is for adults in intensive care or the operating room who are getting a central line in their neck.
This study tests a catheter lock solution called DefenCath (taurolidine and heparin) against a standard heparin lock to see if it reduces central line bloodstream infections in people receiving IV nutrition (total parenteral nutrition) for more than 3 months.
Hear when a new Device Related Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.